AzTrials
AzTrials

Maternal ObesityNCT06917833

Impact of Maternal Body Mass Index on Infant Hypoxic Events at Time of Delivery ,Cross-sectional Study.

An observational study of Maternal Obesity and Hypoxia Neonatal, run by Ain Shams University.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

Offspring from overweight or obese mothers appear to be at up to 38% increased risk of being admitted to the neonatal intensive care unit than the offspring of mothers with a normal BMI. Read more about this study

Who is it for?
Ages 18 to 40 years, women only
Conditions the study is for
Maternal Obesity, Hypoxia Neonatal
What is being tested?
compare infant hypoxic events in both groups
How many people
544 participants
Where
No sites listed yet
Study dates
20 Apr 2025to 28 Jan 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 40 years
  • Women only
  • No healthy volunteers
  • Adult

Study population: 18 - 40 years pregnant females 37 weeks or more

Who may be able to join

  • Age of 18 - 40 years.
  • Term pregnancy (37 weeks gestation or more)
  • Singleton pregnancy
  • Cephalic presentation at time of delivery
  • In labour

Who cannot join

  • Any medical disorders that affect neonatal outcomes (diabetes mellitus, hypertension, mixed connective tissue disorders)
  • Scarred uterus (myomectomy, previous cesarean section)
  • Macrosomic baby>4 kgs
  • Condition jeopardizing the maternal or fetal life (for example: antepartum hemorrhage, pathological CTG, cord prolapse)
  • Liquor abnormalities (oligohydramnios or polyhydramnios).
  • Other indications for cesarean sections for example: placenta accreta spectrum
  • Smokers.
  • Any abnormalities in follow up of delivery regarding partogram.

Trial locations and contacts

No sites are listed yet. Contact the study team or a site near you to ask about taking part.

Esraa Hussein, master contact

01008057054

esraaghoneimy81@gmail.com

About this study

Offspring from overweight or obese mothers appear to be at up to 38% increased risk of being admitted to the neonatal intensive care unit than the offspring of mothers with a normal BMI. In terms of Apgar scores at birth, babies of obese mothers have been reported to have a 31% excess risk of having a low Apgar score (defined at <7 at 1 minute) . Infants born to obese mothers demonstrate a spectrum of outcomes, suggesting that there is a complex interplay of factors that defines the precise altered metabolic environment to which the fetus is exposed and that determines the risk of complications

Read the detailed description

The investigators need to improve understanding of the specific molecular factors that contribute either individually or synergistically to detrimental fetal outcomes. Moreover, The investigators need to identify the essential maternal markers that need to be tightly regulated during pregnancy to improve outcomes. Here in, The investigators discuss the influence of maternal obesity and factors associated with the obesogenic intrauterine environment on fetal lung development and respiratory outcomes in offspring at birth importantly, The investigators identify a series of molecular changes encountered during pregnancy that may program the observed respiratory outcomes in clinical practice. The effects of maternal obesity on severe neonatal asphyxia may be partly explained by traumatic labor, which often results from macrosomia. Another consequence of maternal obesity is fetal hyperinsulinemia, which may be related to chronic hypoxia even without diabetes . Other mechanisms that explain the effect of maternal obesity on neonatal asphyxia include lipotoxicity, placental inflammation and vasculopathy, and cord coiling. Evidence has demonstrated altered gene expression in full-term newborns of mothers with obesity, involving dysregulation of brain development, inflammatory and immune signaling, glucose and lipid homeostasis, and oxidative stress

Being tested
compare infant hypoxic events in both groups
Keywords
maternal obesity, hypoxia neonatal
Medical subject headings
Pregnancy in Obesity, Asphyxia Neonatorum

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • compare infant hypoxic events in both groupsOther

    early neonatal resuscitation will be done by the pediatrician according to the guidelines, APGAR score of the baby will be calculated,, any hypoxic events will be traced and any need of respiratory support for the baby or NICU admission, as well as weight of the baby, mode of delivery and any birth traumas will be recorded.all this will be compared between two groups.

Study groups in NCT06917833
Study groupRoleWhat they receive
group A (case group )women with body mass index equal to 25 kg/m2 or more at time of delivery.
Receives: Other: compare infant hypoxic events in both groups
group B ( control group )women with body mass index (18.5-24.9 kg/m2) at time of delivery
Receives: Other: compare infant hypoxic events in both groups

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Rate of admission to neonatal observation room

    Measured: 6 hours post delivery

Secondary outcomes (5)
  1. Rate of cesarean-sections.

    Measured: 12 hours

  2. Oxygen saturation at birth.

    Measured: 2 hours post delivery

  3. Number of babies with NICU Admission.

    Measured: 6 hours post delivery

  4. Number of babies with birth trauma.

    Measured: 2 hours post delivery

  5. Number of babies with meconium aspiration.

    Measured: 2 hours post delivery

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted9 Apr 2025
  2. Study start20 Apr 2025 (estimated)
  3. Primary completion28 Jan 2026 (estimated)
  4. Study completion28 Jan 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
544 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06917833
Sponsor's protocol ID
MD344/2024
Status last verified
Feb 2025
First submitted
6 Mar 2025
Last updated
9 Apr 2025
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Maternal Obesity and Hypoxia Neonatal, run by Ain Shams University.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 8 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 9 Apr 2025. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Esraa Hussein, master (01008057054, esraaghoneimy81@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Rate of admission to neonatal observation room (time frame: 6 hours post delivery). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 9 Apr 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in